Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage

NCT01082302 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Genital Warts
Perianal Warts

Interventions

DRUG: Polyphenon E (Veregen) 15% ointment
OTHER: Green Tea Beverage with defined catechin content

Sponsor

MediGene

Collaborators

[object Object]